Viridian Therapeutics News and Activities

Viridian Therapeutics is one of the...

• Russell 3000;
• TOB Iconic 10,000.

Viridian Therapeutics is a company listed under the stock ticker VRDN (US).

View the org chart displaying its 25 main executives

Most searched biographies at Viridian Therapeutics

• Stephen Mahoney, Director, President and Chief Executive Officer
• Arlene Morris, Director
• Tomas Kiselak, Chairman of the Board

Create your alert
to follow the executive moves at Viridian Therapeutics.

Viridian Therapeutics has 2,426 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

• Archimed Group has acquired Esperion Therapeutics (posted on July 14 2026).
• The new name of ChemoTech is Neem’s Hill. (posted on July 14 2026).
• MindRank has just announced a $52 Million fundraising (posted on July 14 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Robert Gould - Board Member at Fulcrum Therapeutics

Learn more about the Biotechnology industry

Press releases by Viridian Therapeutics

• Press Releases | Viridian Therapeutics, Inc.
• Press Releases | Viridian Therapeutics, Inc.
• Press Releases | miRagen
• Press Releases | miRagen

Social media about Viridian Therapeutics

• Viridian Therapeutics on Wikipedia, Google News & Yahoo Finance
• Viridian Therapeutics on LinkedIn, X (Twitter) & YouTube